Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:develops |
therapeutics for cancer
|
| gptkbp:focusesOn |
immunotherapy
|
| gptkbp:foundedIn |
2015
|
| gptkbp:funding |
Series A
|
| gptkbp:headquarteredIn |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tilos Therapeutics
|
| gptkbp:keyPeople |
gptkb:Dr._David_A._Kessler
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:profession |
$50 million
|
| gptkbp:website |
www.tilostherapeutics.com
|